BDBM175065 US9688678, 26 (+-)-3-(2-methoxyphenyl)-1-[(5-methoxy-2-pyridyl)sulfonyl]-3-[2-(4-methylpiperazin-1-yl)-6-azaspiro[3.3]heptan-6-yl]-2-oxo-indoline-5-carbonitrile
SMILES: COc1ccc(nc1)S(=O)(=O)N1C2C=CC(=CC2C(N2CC3(CN(C3)N3CCN(C)CC3)C2)(C1=O)c1ccccc1OC)C#N
InChI Key: InChIKey=PFYJSXOIEFLDNQ-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vasopressin V1b receptor (V1b) (Homo sapiens (Human)) | BDBM175065 (US9688678, 26 (+-)-3-(2-methoxyphenyl)-1-[(5-metho...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.5 | -11.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu... | US Patent US9688678 (2017) BindingDB Entry DOI: 10.7270/Q2SN0740 | |||||||||||
More data for this Ligand-Target Pair |